Advanced Search

    Technical Analysis for MRNA - Moderna, Inc.

    Grade Last Price % Change Price Change
    C 149.42 0.84% 1.24
    MRNA closed up 0.84 percent on Thursday, March 23, 2023, on 73 percent of normal volume.
    32 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Flat
    Historical MRNA trend table...
    Date Alert Name Type % Chg
    Doji - Bullish? Reversal 0.00%
    Multiple of Ten Bearish Other 0.00%
    Outside Day Range Expansion 0.00%
    Gapped Up Strength 0.00%
    New Downtrend Bearish 0.84%
    Stochastic Sell Signal Bearish 0.84%
    Multiple of Ten Bearish Other 0.84%
    Overbought Stochastic Strength 0.84%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.76%
    Inside Day Range Contraction -1.76%
    Older End-of-Day Signals for MRNA ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Gap Up Closed about 8 hours ago
    Outside Day about 8 hours ago
    Fell Below Previous Day's Low about 8 hours ago
    Reversed from Up about 8 hours ago
    Fell Below 10 DMA about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators Basic chart:

    Profile

    Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: S&P 500 Cancer Life Sciences Biology Nasdaq 100 Vaccines Coronavirus RNA Cancer Vaccine Messenger RNA

    Is MRNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 23 Moderna's Bancel defends COVID-19 vaccine price at Sanders hearing
    Mar 23 A COVID-19 Vaccine Could Cost You Four Times As Much Soon — Here’s Why
    Mar 23 Moderna, Generation Bio Collaborate To Develop Non-Viral Genetic Medicines
    Mar 23 Generation Bio stock surges ~20% on Moderna pact to develop non-viral genetic drugs
    Mar 23 UPDATE 2-Moderna signs licensing deal with Generation Bio in push beyond COVID
    Mar 23 Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
    Mar 23 Moderna Is Great Value For Money Right Now
    Mar 23 PRESS DIGEST- Wall Street Journal - March 23
    Mar 23 It Will Cost More Than $100 to Get a Moderna Covid Vaccine
    Mar 22 Senators press Moderna CEO on COVID-19 vaccine price hike
    See more MRNA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 217.25
    52 Week Low 115.03
    Average Volume 3,678,545
    200-Day Moving Average 158.21
    50-Day Moving Average 164.96
    20-Day Moving Average 144.53
    10-Day Moving Average 149.31
    Average True Range 6.23
    RSI 46.52
    ADX 24.28
    +DI 19.40
    -DI 24.27
    Chandelier Exit (Long, 3 ATRs) 142.71
    Chandelier Exit (Short, 3 ATRs) 152.35
    Upper Bollinger Bands 156.31
    Lower Bollinger Band 132.76
    Percent B (%b) 0.71
    BandWidth 16.29
    MACD Line -3.14
    MACD Signal Line -5.18
    MACD Histogram 2.0393
    Fundamentals Value
    Market Cap 59.13 Billion
    Num Shares 396 Million
    EPS -2.35
    Price-to-Earnings (P/E) Ratio -63.64
    Price-to-Sales 233.14
    Price-to-Book 22.55
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 159.71
    Resistance 3 (R3) 160.01 156.89 158.00
    Resistance 2 (R2) 156.89 154.27 156.74 157.42
    Resistance 1 (R1) 153.15 152.65 151.59 152.85 156.85
    Pivot Point 150.03 150.03 149.25 149.88 150.03
    Support 1 (S1) 146.29 147.41 144.73 145.99 141.99
    Support 2 (S2) 143.17 145.79 143.02 141.42
    Support 3 (S3) 139.43 143.17 140.85
    Support 4 (S4) 139.13